ArticleThe American journal of surgical pathology2012

Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting.

Meike Körner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.